ErbB2 driven interferon regulatory factor 6 (Irf6) is downregulated in highly invasive BC cell lines but upregulated in less invasive cell lines, and ErbB2 can downregulate the pro-apoptotic protein Irf6 [136]. Here, ERBB2 is linked to breast cancer.